These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Organ-specific cardiac autoantibodies in dilated cardiomyopathy. Frequency and clinical correlates in Polish patients. Bilińska ZT; Caforio AL; Grzybowski J; Michalak E; Kuśmierczyk-Droszcz B; Goldman JH; Haven AJ; Rydlewska-Sadowska W; McKenna WJ; Ruzyłło W Eur Heart J; 1995 Dec; 16(12):1907-11. PubMed ID: 8682025 [TBL] [Abstract][Full Text] [Related]
3. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy. Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945 [TBL] [Abstract][Full Text] [Related]
4. Idiopathic dilated cardiomyopathy: lack of association between circulating organ-specific cardiac antibodies and HLA-DR antigens. Caforio AL; Martinetti M; Schwarz G; Bonifacio E; Gavazzi A; Graziano G; Lorini R; Cuccia M; McKenna WJ; Bottazzo GF Tissue Antigens; 1992 May; 39(5):236-40. PubMed ID: 1412410 [TBL] [Abstract][Full Text] [Related]
6. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy]. Lauer B; Padberg K; Schultheiss HP; Strauer BE Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303 [TBL] [Abstract][Full Text] [Related]
7. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. Latif N; Baker CS; Dunn MJ; Rose ML; Brady P; Yacoub MH J Am Coll Cardiol; 1993 Nov; 22(5):1378-84. PubMed ID: 7901255 [TBL] [Abstract][Full Text] [Related]
9. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Caforio AL; Goldman JH; Haven AJ; Baig KM; McKenna WJ Int J Cardiol; 1996 May; 54(2):157-63. PubMed ID: 8803680 [TBL] [Abstract][Full Text] [Related]
11. Clinical implications of anti-cardiac immunity in dilated cardiomyopathy. Caforio AL; Mahon NG; McKenna WJ Ernst Schering Res Found Workshop; 2006; (55):169-93. PubMed ID: 16329663 [TBL] [Abstract][Full Text] [Related]
12. Use of indirect immunofluorescence and western blotting to assess the role of circulating antimyocardial antibodies in dogs with dilated cardiomyopathy. Cobb MA; Odedra R; Latif N; Dunn MJ Res Vet Sci; 1994 Mar; 56(2):245-51. PubMed ID: 8191016 [TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. Limas CJ; Goldenberg IF; Limas C Circ Res; 1989 Jan; 64(1):97-103. PubMed ID: 2535798 [TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies. Limas CJ; Goldenberg IF; Limas C Circulation; 1995 Feb; 91(3):631-4. PubMed ID: 7828286 [TBL] [Abstract][Full Text] [Related]
15. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Caforio AL; Goldman JH; Baig MK; Haven AJ; Dalla Libera L; Keeling PJ; McKenna WJ Heart; 1997 Jan; 77(1):62-7. PubMed ID: 9038697 [TBL] [Abstract][Full Text] [Related]
16. Cardiocytolytic antimyolemmal antibodies in dilated cardiomyopathy following presentation: observations in 7 patients. Taha TH; Mazeika PK; Oakley CM; Maisch B Int J Cardiol; 1993 Feb; 38(2):133-40. PubMed ID: 8454375 [TBL] [Abstract][Full Text] [Related]
17. Presence of antiheart and antiskeletal muscle glycolipid autoantibodies in the sera of patients with chagasic cardiopathy. Laguens RP; Argel MI; Chambó J; Storino R; Cabeza Meckert PM Can J Cardiol; 1994 Sep; 10(7):769-76. PubMed ID: 7922834 [TBL] [Abstract][Full Text] [Related]